Serial 86658633
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 05 Jan 2023)
What this means for you
Registered since 07 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86658633
- Registration number
- 5153601
- Mark type
- Design / logo
- Filed
- 10 Jun 2015
- Published for opposition
- 20 Dec 2016
- Registered
- 07 Mar 2017
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for use in the treatment of the central nervous system; pharmaceutical preparations and substances for use in the treatment of schizophrenia; pharmaceutical preparations and substances for use in the treatment of circadian rhythm diseases and disorders; pharmaceutical preparations containing iloperidone; and pharmaceutical preparations containing tasimelteon
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
Prior registrations
Prosecution history
- 07 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Jan 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 05 Jan 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Jan 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Jun 2022 — TEAS SECTION 8 & 15 RECEIVED
- 07 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
- 20 Dec 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Dec 2016 — PUBLISHED FOR OPPOSITION
- 30 Nov 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Nov 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 12 Nov 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Nov 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Nov 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Nov 2016 — TEAS REQUEST FOR RECONSIDERATION RECEIVED